Loading...
Acusphere, Inc.
ACUS•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)
Acusphere, Inc. (ACUS) Stock Overview
Explore Acusphere, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ACUSStats details for ACUS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ACUSAnalyst Recommendations details for ACUS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
CEO
Dr. William I. Ramage D.Phil
Headquarters
500 Arsenal Street, Watertown, MA
Founded
2003